ARTICLE | Clinical News
AVI preclinical data
June 13, 2005 7:00 AM UTC
In a mouse model of prostate cancer, intraperitoneal administration of Neugene, a neutrally charged antisense-based androgen receptor antagonist, downregulated androgen receptor levels. Significant pr...